Project description
Digital sweat analysis for health monitoring at home
Self-management of health is an attractive option for chronic conditions such as diabetes, cardiac and respiratory diseases, or for monitoring senior citizens at home. The EU-funded ONALABS project has developed a non-invasive wearable monitoring device that combines multiple microsensors for the continuous, simultaneous monitoring of physical (i.e. heart rate, oxygen saturation, skin temperature) and biochemical (i.e. lactate, glucose levels) parameters. The innovation lies in the fact that sweat instead of blood is used to measure these parameters. The wearable has a friendly interface and connects to mobile devices for data processing. The information is communicated to the hospital, offering physicians an almost real-time update on the health status of patients of any age, from the neonate to the elderly.
Objective
Onalabs Healthcare was born as an ambitious project, technical and emotional focused in premature births where the patient is affected with Congenital Heart Disease (CHD). These patients need 24hour Intensive care monitoring for a period of at least 10 days where 25% of their total blood is extracted to measure 4 biomarkers (Lactate, pH, CO2 and Glucose). This generates pain and a high risk of vain damage as well as potential death due to infections.
Moreover, Heart and lung system problems are the first and fourth cause of death, respectively in Occidental territories, with more than 20 million deaths recorded in 2012. The solution that is offered by Onalabs with its product ‘Cardiopatch’ that addresses a potential market of 872M users. Our product does not rely on the extraction of blood to measure the 4 key parameters. We measure indirectly through a proven system of sweat analysis. This will allow us to also access the sport market and an additional 350M users in the sector of this that we target.
Targetting health care and sport, with a novel disruptive sensor we expect to drive a new market providing solutions providing high impact for society whilst growing to generate profits of 3.4M euros and employ 40 people by 2022
Fields of science
- natural sciencescomputer and information sciencesinternetinternet of things
- medical and health sciencesclinical medicinecardiologypaediatric cardiology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensors
- natural sciencescomputer and information sciencesdata sciencedata processing
- engineering and technologymedical engineeringwearable medical technology
Programme(s)
- H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
- H2020-EU.3.1.4. - Active ageing and self-management of health
- H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
- H2020-EU.3.1.6. - Health care provision and integrated care
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
08290 Barcelona
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.